Celtax 260mg Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Paclitaxel (260mg)
Overview Celtax 260mg Injection
Oncaspar (260mg injectable) is a chemotherapy agent indicated for treating breast, pancreatic, and non-small cell lung cancers. Administration is strictly via injection by a healthcare professional. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Adhere precisely to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be immediately apparent; continue treatment unless otherwise directed. Common side effects include nausea, vomiting, and fatigue. Serious side effects such as edema (hands/lips), alopecia, and weight increase are possible. Your doctor might prescribe additional medication to mitigate side effects. Report any unusual bruising/bleeding, sore throat, mouth sores, or fever immediately. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests are necessary to monitor blood cell levels and liver function. Prior to commencing treatment, inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of antimicrobial agents. Drug interactions are possible; disclose all medications you are taking. This medication is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is crucial throughout the treatment period.
Primary Ingredients of Celtax 260mg Injection
There is no text provided to rephrase.
Uses of Celtax 260mg Injection
Cancers of the breast, lung (non-small cell type), and pancreas.
Major Benefits of Celtax 260mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Celtax 260mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Celtax 260mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Celtax 260mg Injection works:
Onco-Cel 260mg Injection is a chemotherapeutic agent. Its mechanism of action involves disrupting microtubule formation, essential for cancerous cell proliferation. This inhibits tumor growth and ultimately leads to cancer cell death.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Celtax 260mg Injection is unsafe.
PregnancyCONSULT YOUR DOCTOR
Administering Celtax 260mg Injection during pregnancy carries a confirmed risk to the fetus. Its use should be avoided except in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Celtax 260mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
The injectable medication Celtax 260mg may induce adverse reactions that could impair driving ability. While driving between Celtax 260mg injection cycles isn't inherently prohibited, the drug's alcohol content suggests caution regarding driving.
KidneySAFE IF PRESCRIBED
For individuals with kidney conditions, Celtax 260mg Injection is considered safe. No dosage modification is typically needed. Nevertheless, consultation with a physician is advisable if you have pre-existing kidney disease.
LiverCAUTION
Exercise caution when administering Celtax 260mg Injection to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Celtax 260mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Celtax 260mg Injection :
NA
Facts to Know About Celtax 260mg Injection
| Label | Value |
|---|---|
| Chemical Category | Taxane-Based Drugs |
| Developing Habits | No. |
| Type of Therapy | Cancer Drugs |
| Action Class | Taxanes: Antimicrotubule Agents |
3,018 People bought this recently